Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of H1N1 influenza vaccination in rheumatoid arthritis patients treated with rituximab
2009-016789-10Phase 4Active
- Sponsor
- Innate Pharma
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of influenza A (H1N1) 2009 monovalent vaccine in influenza, sponsored by Innate Pharma. Primary endpoints: Proportion of subjects with HI antibody titers ≥1:40, Proportion of subjects with seroconversion or >4-fold increase in antibody titer and 1 more. Started Nov 2009; status: active.
02
Drugs
influenza A (H1N1) 2009 monovalent vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-016789-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016789-10.